Hong Kong Stocks Pharmaceuticals and Healthcare

Partnership. Hong Kong stock medicine because of its own characteristics, is expected to show higher resilience, in this context, Hong Kong stock medicine investment tool: Fortune Hang Seng Hong Kong stock medical for it to play more color. Hong Kong stocks medical is a very good complement to A-share pharmaceutical companies. For example, innovative drugs, CXO, most of the companies are listed in the Hong Kong stock market.In 2018, the Hong Kong Stock Exchange amended the main board listing rules and introduced the "18A" new policy, opening up the unprofitable biological.